Atrial Natriuretic Peptide (ANP) (1-28), rat TFA
| 中文名称 | Atrial Natriuretic Peptide (ANP) (1-28), rat TFA |
|---|---|
| 中文同义词 | |
| 英文名称 | Atrial Natriuretic Peptide (ANP) (1-28), rat TFA |
| 英文同义词 | Atrial Natriuretic Peptide (ANP) (1-28), rat TFA |
| CAS号 | |
| 分子式 | C???H???N??F?O??S? |
| 分子量 | 0 |
| EINECS号 | |
| 相关类别 | |
| Mol文件 | Mol File |
| 结构式 |
Atrial Natriuretic Peptide (ANP) (1-28), rat TFA 性质
| 形态 | 固体 |
|---|---|
| 颜色 | 白色至米白色 |
Atrial Natriuretic Peptide (ANP) (1-28), rat (TFA) 是心房利钠肽 (ANP) 在大鼠中的主要循环形式，强效抑制血管紧张素 II (Ang II)-刺激的内皮素-1 (endothelin-1) 分泌。
Endothelin-1
Rat ANP (1-28) and rat BNP-45, which are the respective major circulating forms of ANP and BNP in rats, potently inhibited Ang II-stimulated endothelin-1 secretion in a concentration-dependent manner. Rat ANP (5-25) is less effective that Rat ANP(1-28) with respect to inhibiting immunoreactive (ir)-endothelin-1 secretion and increasing cellular cyclic GMP. Rat ANP (1-28) inhibits the secretion of ir-endothelin-1 in a concentration-dependent manner between 0.01 and 1 μM.